226 related articles for article (PubMed ID: 26554885)
1. How I diagnose and treat neutropenia.
Dale DC
Curr Opin Hematol; 2016 Jan; 23(1):1-4. PubMed ID: 26554885
[TBL] [Abstract][Full Text] [Related]
2. Cyclic and chronic neutropenia.
Dale DC; Welte K
Cancer Treat Res; 2011; 157():97-108. PubMed ID: 21052952
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
Ravaud A; Chevreau C; Cany L; Houyau P; Dohollou N; Roché H; Soubeyran P; Bonichon F; Mihura J; Eghbali H; Tabah I; Bui BN
J Clin Oncol; 1998 Sep; 16(9):2930-6. PubMed ID: 9738560
[TBL] [Abstract][Full Text] [Related]
4. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K
Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
[TBL] [Abstract][Full Text] [Related]
5. An update on the diagnosis and treatment of chronic idiopathic neutropenia.
Dale DC; Bolyard AA
Curr Opin Hematol; 2017 Jan; 24(1):46-53. PubMed ID: 27841775
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.
Kushner BH; Heller G; Kramer K; Cheung NK
Cancer; 2000 Nov; 89(10):2122-30. PubMed ID: 11066054
[TBL] [Abstract][Full Text] [Related]
7. [Reference guide for adult chronic neutropenia].
Yokoyama Y; Takami A; Mori Y; Sato S; Suzuki T; Gosho M; Obara N; Miyazaki Y; Akashi K; Chiba S;
Rinsho Ketsueki; 2018; 59(7):845-857. PubMed ID: 30078793
[TBL] [Abstract][Full Text] [Related]
8. Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia.
Siddiqui T; Burney IA; Kakepoto GN; Khurshid M; Salam A; Smego RA
J Pak Med Assoc; 2002 May; 52(5):206-10. PubMed ID: 12174492
[TBL] [Abstract][Full Text] [Related]
9. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
10. [Severe congenital neutropenia: trends in diagnosis and therapy].
Zeidler C; Schwinzer B; Welte K
Klin Padiatr; 2000; 212(4):145-52. PubMed ID: 10994541
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and management of patients with isolated neutropenia.
Newburger PE; Dale DC
Semin Hematol; 2013 Jul; 50(3):198-206. PubMed ID: 23953336
[TBL] [Abstract][Full Text] [Related]
12. Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensity.
Ribas A; Albanell J; Bellmunt J; Solé-Calvo LA; Bermejo B; Gallardo E; Vidal R; Vera R; Eres N; Carulla J; Baselga J
J Clin Oncol; 1996 May; 14(5):1573-80. PubMed ID: 8622074
[TBL] [Abstract][Full Text] [Related]
13. [Chronic neutropenia - experience from the Department of Immunology, Children's Memorial Health Institute].
Klaudel-Dreszler M; Pietrucha B; Skopczynska H; Pac M; Kurenko-Deptuch M; Heropolitanska-Pliszka E; Wolska-Kusnierz B; Maslanka K; Bernatowska E
Med Wieku Rozwoj; 2007; 11(2 Pt 1):145-52. PubMed ID: 17625284
[TBL] [Abstract][Full Text] [Related]
14. Severe congenital neutropenia.
Welte K; Zeidler C; Dale DC
Semin Hematol; 2006 Jul; 43(3):189-95. PubMed ID: 16822461
[TBL] [Abstract][Full Text] [Related]
15. Hematologic Conditions: Leukopenia.
Lam L; Mumford J; Keber B; Flanagan B
FP Essent; 2019 Oct; 485():11-16. PubMed ID: 31613563
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.
Perrier L; Lefranc A; Pérol D; Quittet P; Schmidt-Tanguy A; Siani C; de Peretti C; Favier B; Biron P; Moreau P; Bay JO; Lissandre S; Jardin F; Espinouse D; Sebban C
Appl Health Econ Health Policy; 2013 Apr; 11(2):129-38. PubMed ID: 23435861
[TBL] [Abstract][Full Text] [Related]
19. Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.
Vellenga E; Uyl-de Groot CA; de Wit R; Keizer HJ; Löwenberg B; ten Haaft MA; de Witte TJ; Verhagen CA; Stoter GJ; Rutten FF; Mulder NH; Smid WM; de Vries EG
J Clin Oncol; 1996 Feb; 14(2):619-27. PubMed ID: 8636779
[TBL] [Abstract][Full Text] [Related]
20. [Granulocyte colony-stimulating factor in neutropenia secondary to lymphoid bone marrow infiltration].
Hammerstrøm J
Tidsskr Nor Laegeforen; 1996 Feb; 116(4):484-6. PubMed ID: 8644050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
